EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Understanding the Tumor Microenvironment and Therapy Resistance in Head and Neck Squamous Cell Carcinoma

Abhinav Bagchi iD, Ratna B Ray iD

Cells · 25.12.2025 · 15 (1) · 44

DOI: 10.3390/cells15010044 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 25.12.2025. Verfasst von Abhinav Bagchi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Saint Louis University, 1100 South Grand Boulevard, St. Louis, MO 63104, USA. Hauptthemen laut MEDLINE: Tumor Microenvironment, Drug Resistance, Neoplasm, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 171 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCR NIH HHS, NEI NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Head and neck squamous cell carcinoma (HNSCC) is a group of cancers arising in the oropharyngeal and laryngeal regions. Lifestyle choices such as smoking, tobacco chewing, alcohol consumption, and human papillomavirus (HPV) infection are key risk factors. Therapeutic options include surgical resection, chemoradiotherapy, EGFR-targeting therapy, and immunotherapy. However, the treatments are limited by drug resistance, relapses, and poor response to immunotherapy, especially in advanced diseases. The difference in tissue types and HPV infection status may lead to significant variations in their tumor microenvironment (TME). The heterogeneity contributes to poor treatment response and the development of therapeutic resistance. Therefore, it is critical to have a deeper understanding of the complexities and heterogeneity in TME and its role in treatment resistance. In this review, we focused on tumor heterogeneity and the role of cancer and non-cancer cells in therapeutic resistance. We discussed the studies on human HNSCC, especially HPV-negative, and presented the diversity in the tumor microenvironment and treatment response. Furthermore, we address the existing and experimental therapeutics that target therapy resistance and may lead to a better understanding of the disease and improve therapeutic outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentDrug Resistance, NeoplasmSquamous Cell Carcinoma of Head and NeckHead and Neck NeoplasmsHumansAnimalsHuman Papillomavirus Viruses

Stichwörter der Autor:innen

head and neck cancertherapeutic strategytumor microenvironment

Autor:innen und Institutionen

  • Department of Pathology, Saint Louis University, 1100 South Grand Boulevard, St. Louis, MO 63104, USA.

ORCID-Profile: Abhinav Bagchi, Ratna B Ray

Förderung

  • NIDCR NIH HHS
  • NEI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Bagchi, A., & Ray, R. B. (2025). Understanding the Tumor Microenvironment and Therapy Resistance in Head and Neck Squamous Cell Carcinoma. Cells, 15(1), 44. https://doi.org/10.3390/cells15010044

Vancouver

Bagchi A, Ray RB. Understanding the Tumor Microenvironment and Therapy Resistance in Head and Neck Squamous Cell Carcinoma. Cells. 2025;15(1):44. doi:10.3390/cells15010044

BibTeX
@article{Bagchi2025,
  author = {Bagchi, Abhinav and Ray, Ratna B},
  title = {Understanding the Tumor Microenvironment and Therapy Resistance in Head and Neck Squamous Cell Carcinoma},
  journal = {Cells},
  year = {2025},
  volume = {15},
  number = {1},
  pages = {44},
  doi = {10.3390/cells15010044}
}
Kostenlos starten →